Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Abstract Text:

B I Glanz,C M Holland,S A Gauthier,E L Amunwa,Z Liptak,M K Houtchens,R A Sperling,S J Khoury,C R G Guttmann,H L Weiner,B I Glanz,C M Holland,S A Gauthier,E L Amunwa,Z Liptak,M K Houtchens,R A Sperling,S J Khoury,C R G Guttmann,H L Weiner,

Cognitive dysfunction is common in patients with multiple sclerosis (MS), and has been associated with MRI measures of lesion burden and atrophy. Little is known about the prevalence of cognitive impairment in patients with early MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course are also unclear. This study used a brief battery of cognitive tests to determine the prevalence and pattern of cognitive impairment in patients with clinically isolated syndromes or newly diagnosed MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course were also examined. Ninety-two patients with clinically isolated syndromes or the diagnosis of MS within the last 3 years participating in the CLIMB study underwent a neurologic examination, neuropsychological evaluation and MRI at 1.5 T. Forty-nine percent of patients were impaired on one or more cognitive measures. There were no significant correlations between cognitive scores and MRI measures of disease severity including total T2 lesion volume, normal appearing white matter volume, grey matter volume, and brain parenchymal fraction. These findings suggest that cognitive impairment may predate the appearance of gross structural abnormalities on MRI and serve as an early marker of disease activity in MS.

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Publishing Authors By Initials

BI Glanz,CM Holland,SA Gauthier,EL Amunwa,Z Liptak,MK Houtchens,RA Sperling,SJ Khoury,CR Guttmann,HL Weiner,BI Glanz,CM Holland,SA Gauthier,EL Amunwa,Z Liptak,MK Houtchens,RA Sperling,SJ Khoury,CR Guttmann,HL Weiner,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Multiple sclerosis (Houndmills, Basingstoke, Engla

VOLUME: 13

Page Numbers: 1004-10

Journal Abbreviation: Mult. Scler.

ISSN: 1352-4585

DAY: 10

MONTH: 07

YEAR: 2007

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9509185

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

AFFILIATION: Department of Neurology, Brigam and Women's Hospital, Harvard Medical School, Boston, MA, USA. bglanz@partners.org

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mult Scler

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis Related Publications

• A randomized clinical trial comparing the effect of maternal intravenous hydration and placebo on the amniotic fluid index in oligohydramnios.
• ADCS Prevention Instrument Project: quality of life assessment (QOL).
• Adapting a dynamic model of interorganizational cooperation to the health care sector.
• Anisotropic Poisson's ratio and compression modulus of cortical bone determined by speckle interferometry.
• Bayesian parallel imaging with edge-preserving priors.
• Binding of mitochondrial leader sequences to Tom20 assessed using a bacterial two-hybrid system shows that hydrophobic interactions are essential and that some mutated leaders that do not bind Tom20 can still be imported.
• Biomechanical properties of the lower uterine segment above and below the reflection of the urinary bladder flap.
• Cardiovascular disease and subsequent kidney disease.
• Caregiving burden responses differ for Internet and telephone data collection.
• Chronic low back pain in older adults: What physicians know, what they think they know, and what they should be taught.
• Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
• Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner.
• Delivery of drugs and macromolecules to mitochondria.
• Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
• Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.
• Electronic health records: high-quality electronic data for higher-quality clinical research.
• Expression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidney.
• How the parallel channels of the retina contribute to depth processing.
• Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T.
• Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
• Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
• Recovery preference exploration: analysis of patient feedback after imagined scenarios.
• Reengineering CCA-adding enzymes to function as (U,G)- or dCdCdA-adding enzymes or poly(C,A) and poly(U,G) polymerases.
• Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.
• Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
• Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.
• The hairless mouse ear: an in vivo model for studying wound neovascularization.
• The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b.
• Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis.
• X-ray absorption spectroscopic characterization of the molybdenum site of Escherichia coli dimethyl sulfoxide reductase.